<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30349393</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1179-1349</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Clinical epidemiology</Title>                <ISOAbbreviation>Clin Epidemiol</ISOAbbreviation>            </Journal>            <ArticleTitle>Familial risks of second primary cancers and mortality in ovarian cancer patients.</ArticleTitle>            <Pagination>                <MedlinePgn>1457-1466</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S174173</ELocationID>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">With improving survival in ovarian cancer, second primary cancers (SPCs) and their etiological foundations are becoming an issue. The ways in which family history may influence the occurrence of SPCs and the related mortality are not well known.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Based on the Swedish Family-Cancer Database, we identified 11,300 ovarian cancer patients and followed them for diagnoses of SPCs until the end of 2015. Relative risks (RRs) of SPC in patients who had parents or siblings diagnosed with the same cancer (positive family history) were compared to those in patients without a family history (negative family history). Causes of death were compared between patients with and without SPC.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 1,111 (9.8%) ovarian cancer patients developed SPC with a median follow-up of 8 years. The impact of a family history of cancer on the risk of the same cancer as SPC was significant for colon (RR<sub>positive family history</sub> [95% CI] vs RR<sub>negative family history</sub> [95% CI]: 4.95 [3.03-8.09] vs 2.00 [1.63-2.47]), lung (3.32 [1.88-5.84] vs 1.45 [1.16-1.83]), and breast (2.08 [1.58-2.73] vs 1.01 [0.88-1.15]) cancers. With a family history of any cancer, the RR for non-ovarian SPCs was 1.66 (1.54-1.74), in contrast to 1.38 (1.24-1.54) for SPCs without any family history (<i>P</i>-trend &lt;0.001). Accounting for 42.1% of all deaths, SPC was found to be the main cause of death for patients with SPC.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">A family history of a particular cancer contributed to an increased risk of SPC at the same site. Therefore, considering family history at the time of diagnosis of ovarian cancer may alert physicians to a syndromic background, management of which may help the patient and her family members.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Guoqiao</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chattopadhyay</LastName>                    <ForeName>Subhayan</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Försti</LastName>                    <ForeName>Asta</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sundquist</LastName>                    <ForeName>Kristina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Family Medicine and Community Health.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Community-Based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hemminki</LastName>                    <ForeName>Kari</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Clin Epidemiol</MedlineTA>            <NlmUniqueID>101531700</NlmUniqueID>            <ISSNLinking>1179-1349</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">cause of death</Keyword>            <Keyword MajorTopicYN="N">cumulative incidence</Keyword>            <Keyword MajorTopicYN="N">familial cancer</Keyword>            <Keyword MajorTopicYN="N">second primary cancer</Keyword>        </KeywordList>        <CoiStatement>Author contributions KH proposed the research conception and study design. KS, KH, GZ, and SC contributed to the collection and assembly of data. GZ, KH, SC, and AF were responsible for the data analysis and interpretation. KH completed the draft of the manuscript, and all the authors revised it critically for important intellectual content. The final manuscript was reviewed and approved by all authors. All authors are accountable for all aspects of the work. Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30349393</ArticleId>            <ArticleId IdType="doi">10.2147/CLEP.S174173</ArticleId>            <ArticleId IdType="pii">clep-10-1457</ArticleId>            <ArticleId IdType="pmc">PMC6188204</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>